Log in

Relevant bibliographies by topics / Bioidentical hormones / Journal articles

To see the other types of publications on this topic, follow the link: Bioidentical hormones.

Journal articles on the topic 'Bioidentical hormones'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Bioidentical hormones.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Callejas, Miriam Martinez. "Understanding bioidentical hormones and their effect on quality of life." Journal of Aesthetic Nursing 8, no. 10 (2019): 467–71. http://dx.doi.org/10.12968/joan.2019.8.10.467.

Full text

Abstract:

It is important to understand the functions of the body's hormones and the options available to make the right choices for use in treating the symptoms of menopause. Bioidentical hormones are compounds that have exactly the same chemical and molecular structure as endogenous human hormones. In contrast, non-bioidentical—or synthetic—hormones are structurally dissimilar from endogenous hormones. Although it has been available for years, bioidentical compounded hormone therapy has gained popularity only recently. This article highlights the main functions of these hormones and how hormone imbala

APA, Harvard, Vancouver, ISO, and other styles

2

Callejas, Alison Culkin Miriam Martinez. "Understanding bioidentical hormones and their effect on quality of life." Journal of Prescribing Practice 2, no. 1 (2020): 18–22. http://dx.doi.org/10.12968/jprp.2020.2.1.18.

Full text

Abstract:

It is important to understand the functions of the body's hormones and the options available to make the right choices for use in treating the symptoms of menopause. Bioidentical hormones are compounds that have exactly the same chemical and molecular structure as endogenous human hormones. In contrast, non-bioidentical—or synthetic—hormones are structurally dissimilar from endogenous hormones. Although it has been available for years, bioidentical compounded hormone therapy has gained popularity only recently. This article highlights the main functions of these hormones and how hormone imbala

APA, Harvard, Vancouver, ISO, and other styles

3

Sites, Cynthia K. "Bioidentical Hormones for Menopausal Therapy." Women's Health 4, no. 2 (2008): 163–71. http://dx.doi.org/10.2217/17455057.4.2.163.

Full text

Abstract:

'Bioidentical hormones' is a term created by the lay media to refer to chemicals derived from plants that are modified to be structurally identical to endogenous human hormones. These compounds include estradiol, estrone, estriol, progesterone, testosterone and dehydroepiandrosterone when prescribed for menopausal women. Patients assume bioidentical hormones are natural and safer than synthetic hormones with regard to the risk of developing breast cancer and other diseases, but there is little evidence to support this belief. Proponents of this therapy also support the use of salivary hormone

APA, Harvard, Vancouver, ISO, and other styles

4

Richman, Susan. "Bioidentical hormones." American Journal of Obstetrics and Gynecology 203, no. 6 (2010): e7. http://dx.doi.org/10.1016/j.ajog.2010.08.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Martins, Vera, Nick Legroux, Monica Lascar, and Marion Gluck. "Compounded bioidentical HRT improves quality of life and reduces menopausal symptoms." Journal of Prescribing Practice 2, no. 7 (2020): 384–90. http://dx.doi.org/10.12968/jprp.2020.2.7.384.

Full text

Abstract:

Bioidentical hormone replacement therapy, a form of hormone balancing and treatment that uses hormones identical to the ones naturally produced by the body, is an effective and well-tolerated method of hormone replacement therapy. The Marion Gluck Clinic conducted a small-scale study to assess the effectiveness of compounded bioidentical hormone replacement therapy treatment protocols and their impact on the quality of life of women experiencing symptoms of the menopause. Quality of life was assessed by completing the Greene Climacteric Scale questionnaire before and after bioidentical hormone

APA, Harvard, Vancouver, ISO, and other styles

6

Chervenak, Judi. "Bioidentical hormones for maturing women." Maturitas 64, no. 2 (2009): 86–89. http://dx.doi.org/10.1016/j.maturitas.2009.08.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Jaffe, Robert B., Leslie Salomone, and Richard J. Santen. "Bioidentical (Natural) Hormones and Menopause." Journal of Clinical Endocrinology & Metabolism 90, no. 11 (2005): 0. http://dx.doi.org/10.1210/jcem.90.11.9994.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Quilligan, Edward J., Moon H. Kim, and Thomas J. Garite. "Live webinar on bioidentical hormones." American Journal of Obstetrics and Gynecology 203, no. 6 (2010): 519. http://dx.doi.org/10.1016/j.ajog.2010.08.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

FRIEDEN, JOYCE. "FDA Cracks Down on Bioidentical Hormones." Clinical Endocrinology News 3, no. 2 (2008): 1–2. http://dx.doi.org/10.1016/s1558-0164(08)70044-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Fugh-Berman, Adriane, and Jenna Bythrow. "Bioidentical Hormones for Menopausal Hormone Therapy: Variation on a Theme." Journal of General Internal Medicine 22, no. 7 (2007): 1030–34. http://dx.doi.org/10.1007/s11606-007-0141-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Pinter, Bojana. "The mis(t)ery of bioidentical hormones." Maturitas 81, no. 1 (2015): 158. http://dx.doi.org/10.1016/j.maturitas.2015.02.175.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Panay, Nick, and Anna Fenton. "Bioidentical hormones: what is all the hype about?" Climacteric 13, no. 1 (2010): 1–3. http://dx.doi.org/10.3109/13697130903550250.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Huntley, A. L. "Compounded or confused? Bioidentical hormones and menopausal health." Menopause International 17, no. 1 (2011): 16–18. http://dx.doi.org/10.1258/mi.2011.011009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Perkins, Meghan S., Renate Louw-du Toit, and Donita Africander. "Hormone therapy and breast cancer: emerging steroid receptor mechanisms." Journal of Molecular Endocrinology 61, no. 4 (2018): R133—R160. http://dx.doi.org/10.1530/jme-18-0094.

Full text

Abstract:

Although hormone therapy is widely used by millions of women to relieve symptoms of menopause, it has been associated with several side effects such as coronary heart disease, stroke and increased invasive breast cancer risk. These side effects have caused many women to seek alternatives to conventional hormone therapy, including the controversial custom-compounded bioidentical hormone therapy suggested to not increase breast cancer risk. Historically, estrogens and the estrogen receptor were considered the principal factors promoting breast cancer development and progression; however, a role

APA, Harvard, Vancouver, ISO, and other styles

15

L’Hermite, M. "Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal." Climacteric 20, no. 4 (2017): 331–38. http://dx.doi.org/10.1080/13697137.2017.1291607.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Bhavnani, Bhagu R., and Frank Z. Stanczyk. "Misconception and Concerns about Bioidentical Hormones Used for Custom-Compounded Hormone Therapy." Journal of Clinical Endocrinology & Metabolism 97, no. 3 (2012): 756–59. http://dx.doi.org/10.1210/jc.2011-2492.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Holtorf, Kent. "The Bioidentical Hormone Debate: Are Bioidentical Hormones (Estradiol, Estriol, and Progesterone) Safer or More Efficacious than Commonly Used Synthetic Versions in Hormone Replacement Therapy?" Postgraduate Medicine 121, no. 1 (2009): 73–85. http://dx.doi.org/10.3810/pgm.2009.01.1949.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Miller, Howard. "Response to “The Bioidentical Hormone Debate: Are Bioidentical Hormones (Estradiol, Estriol, and Progesterone) Safer or More Efficacious than Commonly Used Synthetic Versions in Hormone Replacement Therapy?”." Postgraduate Medicine 121, no. 4 (2009): 172. http://dx.doi.org/10.3810/pgm.2009.07.2042.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Sood, Richa, Roger A. Warndahl, Darrell R. Schroeder, et al. "Bioidentical compounded hormones: A pharmacokinetic evaluation in a randomized clinical trial." Maturitas 74, no. 4 (2013): 375–82. http://dx.doi.org/10.1016/j.maturitas.2013.01.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Santoro, Nanette, Glenn D. Braunstein, Cherie L. Butts, Kathryn A. Martin, Michael McDermott, and JoAnn V. Pinkerton. "Compounded Bioidentical Hormones in Endocrinology Practice: An Endocrine Society Scientific Statement." Journal of Clinical Endocrinology & Metabolism 101, no. 4 (2016): 1318–43. http://dx.doi.org/10.1210/jc.2016-1271.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Sood, R., L. Shuster, R. Smith, A. Vincent, and A. Jatoi. "Counseling Postmenopausal Women about Bioidentical Hormones: Ten Discussion Points for Practicing Physicians." Journal of the American Board of Family Medicine 24, no. 2 (2011): 202–10. http://dx.doi.org/10.3122/jabfm.2011.02.100194.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

&NA;. ""Bioidentical hormones" should be considered to have the same risks as traditional HRT,." Reactions Weekly &NA;, no. 1023 (2004): 3. http://dx.doi.org/10.2165/00128415-200410230-00006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Tsushima, Yumiko, and Alexandra Mikhael. "Bioidentical Hormone Replacement Therapy at a Hormone Clinic Causing Significant Virilization in a Post-Menopausal Women." Journal of the Endocrine Society 5, Supplement_1 (2021): A778. http://dx.doi.org/10.1210/jendso/bvab048.1583.

Full text

Abstract:

Abstract Introduction: Bioidentical hormones (BH) are compounds that have the exact chemical and molecular composition as hormones produced in our bodies. The term typically refers to testosterone, progesterone, and androgens. Compounding pharmacies market these products as being individually tailored, safer, and more effective than modified hormones synthesized under FDA supervision. These compounded products are not subject to FDA approval for dose, purity, safety, or efficacy, which poses a risk to patients. Our case highlights the dangers of unmonitored BH replacement therapy (BHRT) use an

APA, Harvard, Vancouver, ISO, and other styles

24

Bosarge, Penelope M., and Sarah Freeman. "Bioidentical Hormones, Compounding, and Evidence-Based Medicine: What Women's Health Practitioners Need to Know." Journal for Nurse Practitioners 5, no. 6 (2009): 421–27. http://dx.doi.org/10.1016/j.nurpra.2009.03.011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Tatarchuk, T. F., Z. M. Dubossarska, V. I. Pyrohova, et al. "On the use of sex steroids in women during the COVID-19 pandemic." Reproductive Endocrinology, no. 58 (May 27, 2021): 9–16. http://dx.doi.org/10.18370/2309-4117.2021.58.9-16.

Full text

Abstract:

The document was approved at an expanded meeting of the Ukrainian Society of Gynecological Endocrinology with the involvement of all board members and representatives of the Association of Obstetricians-Gynecologists of Ukraine, the Association of Pharmacologists of Ukraine, the Association of Anesthesiologists of Ukraine, as well during the Third Ukrainian School of Gynecological and Reproductive Endocrinology with international participation ISGE 19–20.03.21.The COVID-19 pandemic has significantly impacted medical practice, in terms of organizational and clinical practices, posing a number o

APA, Harvard, Vancouver, ISO, and other styles

26

Fishman, Jennifer R., Michael A. Flatt, and Richard A. Settersten. "Bioidentical hormones, menopausal women, and the lure of the “natural” in U.S. anti-aging medicine." Social Science & Medicine 132 (May 2015): 79–87. http://dx.doi.org/10.1016/j.socscimed.2015.02.027.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Shufelt, Chrisandra L., and JoAnn E. Manson. "Menopausal Hormone Therapy and Cardiovascular Disease: The Role of Formulation, Dose, and Route of Delivery." Journal of Clinical Endocrinology & Metabolism 106, no. 5 (2021): 1245–54. http://dx.doi.org/10.1210/clinem/dgab042.

Full text

Abstract:

Abstract Context This mini-review provides an overview of menopausal hormone therapy (HT) and cardiovascular disease (CVD) risk, with a focus on the role of hormone formulation, dose, and route of delivery. Methods This summary is based on authors’ knowledge in the field of menopausal HT and supplemented by a PubMed search using the terms “menopause hormone therapy,” “transdermal,” “estradiol,” “conjugated estrogens,” “bioidentical,” “cardiovascular disease,” “lipoproteins,” “glucose,” “progestogens,” “low dose.” Results Available evidence indicates that oral unopposed estrogens have a favorab

APA, Harvard, Vancouver, ISO, and other styles

28

Iftikhar, Salma, Lynne T. Shuster, Ruth E. Johnson, Sarah M. Jenkins, and Dietlind L. Wahner-Roedler. "Use of Bioidentical Compounded Hormones for Menopausal Concerns: Cross-Sectional Survey in an Academic Menopause Center." Journal of Women's Health 20, no. 4 (2011): 559–65. http://dx.doi.org/10.1089/jwh.2009.1915.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Files, Julia A., Marcia G. Ko, and Sandhya Pruthi. "Bioidentical Hormone Therapy." Mayo Clinic Proceedings 86, no. 7 (2011): 673–80. http://dx.doi.org/10.4065/mcp.2010.0714.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Richardson, Marcie K. "Bioidentical hormone therapy." Menopause 23, no. 4 (2016): 353–54. http://dx.doi.org/10.1097/gme.0000000000000629.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Stuenkel, Cynthia A., and JoAnn E. Manson. "Compounded Bioidentical Hormone Therapy." JAMA Internal Medicine 177, no. 12 (2017): 1719. http://dx.doi.org/10.1001/jamainternmed.2017.5141.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Pinkerton, JoAnn V., and Nanette Santoro. "Compounded bioidentical hormone therapy." Menopause 22, no. 9 (2015): 926–36. http://dx.doi.org/10.1097/gme.0000000000000420.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Kaunitz, Andrew M., and Jonathan D. Kaunitz. "Compounded bioidentical hormone therapy." Menopause 22, no. 9 (2015): 919–20. http://dx.doi.org/10.1097/gme.0000000000000484.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

MacLennan, Alastair H., and David W. Sturdee. "The ‘bioidentical/bioequivalent’ hormone scam." Climacteric 9, no. 1 (2006): 1–3. http://dx.doi.org/10.1080/13697130500487166.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Boothby, Lisa A., Paul L. Doering, and Simon Kipersztok. "Bioidentical hormone therapy: a review." Menopause 11, no. 3 (2004): 356–67. http://dx.doi.org/10.1097/01.gme.0000094356.92081.ef.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Rosenthal, M. S. "Ethical problems with bioidentical hormone therapy." International Journal of Impotence Research 20, no. 1 (2007): 45–52. http://dx.doi.org/10.1038/sj.ijir.3901622.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Pattimakiel, Lynn, and Holly L. Thacker. "Bioidentical hormone therapy: Clarifying the misconceptions." Cleveland Clinic Journal of Medicine 78, no. 12 (2011): 829–36. http://dx.doi.org/10.3949/ccjm.78a.10114.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Dilks, Aly, and Emma Soos. "Bioidentical hormone replacement therapy: implications for practice." Journal of Aesthetic Nursing 8, no. 4 (2019): 166–71. http://dx.doi.org/10.12968/joan.2019.8.4.166.

Full text

Abstract:

In recent years, there has been a cultural shift towards greater acknowledgement of the effects of menopause on women's health, wellbeing and their relationships at both work and home, and an awareness of the very acute need for these symptoms to be monitored and addressed holistically as and when they change. No longer is it accepted that women should just ‘get on with it’, or feel helpless that there are few resources available to help them. As a result, there has been an increase in interest in bio-identical hormone replacement therapy (BHRT), especially following a greater media coverage o

APA, Harvard, Vancouver, ISO, and other styles

39

Cicinelli, Ettore. "Bioidentical estradiol gel for hormone therapy in menopause." Expert Review of Obstetrics & Gynecology 2, no. 4 (2007): 423–30. http://dx.doi.org/10.1586/17474108.2.4.423.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Newson, Louise, and Janice Rymer. "The dangers of compounded bioidentical hormone replacement therapy." British Journal of General Practice 69, no. 688 (2019): 540–41. http://dx.doi.org/10.3399/bjgp19x706169.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Files, Julia A., Lisa N. Kransdorf, Marcia Ko, et al. "Bioidentical hormone therapy: An assessment of provider knowledge." Maturitas 94 (December 2016): 46–51. http://dx.doi.org/10.1016/j.maturitas.2016.08.014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Cirigliano, Michael. "Bioidentical Hormone Therapy: A Review of the Evidence." Journal of Women's Health 16, no. 5 (2007): 600–631. http://dx.doi.org/10.1089/jwh.2006.0311.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Gersak, Ksenija, Miriam Z. Gersak, and Lucija Vrabic Dezman. "Overtreatment with “bioidentical” hormone replacement therapy – a case report." Maturitas 81, no. 1 (2015): 148. http://dx.doi.org/10.1016/j.maturitas.2015.02.147.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Pinkerton, JoAnn V. "Think Twice Before Prescribing Custom-Compounded Bioidentical Hormone Therapy." Journal of Women's Health 23, no. 8 (2014): 631–33. http://dx.doi.org/10.1089/jwh.2014.1505.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Whelan, Anne Marie, Jean-Pierre Thebeau, Tannis M. Jurgens, and Eileen Hurst. "Bioidentical hormone therapy: Nova Scotia pharmacists´ knowledge and beliefs." Pharmacy Practice (Internet) 10, no. 3 (2012): 159–67. http://dx.doi.org/10.4321/s1886-36552012000300006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Boothby, Lisa A., and Paul L. Doering. "Bioidentical hormone therapy: a panacea that lacks supportive evidence." Current Opinion in Obstetrics and Gynecology 20, no. 4 (2008): 400–407. http://dx.doi.org/10.1097/gco.0b013e3283081ae9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Pinkerton, JoAnn V. "What are the concerns about custom-compounded “bioidentical” hormone therapy?" Menopause 21, no. 12 (2014): 1298–300. http://dx.doi.org/10.1097/gme.0000000000000376.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Yuksel, Nese, Laetitia Treseng, Bushra Malik, and Ubaka Ogbogu. "Promotion and marketing of bioidentical hormone therapy on the internet." Menopause 24, no. 10 (2017): 1129–35. http://dx.doi.org/10.1097/gme.0000000000000901.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Pinkerton, JoAnn V. "Concerns about safety and efficacy of compounded bioidentical hormone therapy." Menopause 28, no. 8 (2021): 847–49. http://dx.doi.org/10.1097/gme.0000000000001813.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Kozlov, P. V. "The Estrogen Component of Menopausal Hormone Therapy as a Preventive Strategy." Doctor.Ru 19, no. 8 (2020): 77–79. http://dx.doi.org/10.31550/1727-2378-2020-19-8-77-79.

Full text

Abstract:

Objective of the Review: To discuss clinical and experimental research data, focused on some non-reproductive effects of estrogens and the role of menopausal hormone therapy (MHT) in ensuring women’s health during aging and preventing age-associated diseases. Key Points: Combination oral MHT is most effective in preventing cardiovascular diseases, metabolic syndrome, and diabetes mellitus, when initiated during the menopause transition. Individually tailored regimens containing the bioidentical estrogen 17β-estradiol and dydrogesterone, a metabolically neutral gestagen, ensure highly safe MHT.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!